ARA-290 16mg

Within Europe this product is supplied including bacteriostatic water; outside Europe only the peptide vial is provided. For research use only – not for human or veterinary use.   Product Overview ARA-290 is a research peptide developed for investigations into regulatory signalling pathways, cellular communication modelling and structure–function evaluation under controlled laboratory conditions. This lyophilized 16 mg preparation supports reproducible in-vitro analysis of stability, identity and mechanistic behaviour within pathway-level biochemical systems.   Peptide Overview Since the early 2000s ARA-290 has been incorporated into studies focused on biochemical signalling modulation and receptor-associated pathway behaviour. Between 2005 and 2020 research groups increasingly utilised ARA-290 in mechanistic models examining regulatory cascades, intracellular communication and structural–function response patterns across controlled in-vitro environments. From 2020 to 2025 the peptide remained a reference compound in advanced pathway-modelling studies due to its consistent analytical profile and reproducible laboratory performance.   Historical Background and Scientific Context Interest in ARA-290 grew during the 2010s as laboratories expanded research into peptide-driven signalling mechanisms and pathway-specific biochemical regulation. Researchers established reproducible frameworks for evaluating receptor-associated behaviour, structural modifications and regulated intracellular response dynamics. Between 2015 and 2025 ARA-290 became increasingly relevant in in-vitro models of biochemical communication, providing a stable and analytically defined reference structure suitable for comparative mechanistic studies and structure–function modelling experiments.   Mechanistic Focus in Research

• Biochemical signalling and pathway-modulation modelling
• Receptor-associated interaction analysis
• Structure–function evaluation in controlled in-vitro systems
• Comparative modelling of regulatory peptide behaviour
• Intracellular communication and mechanistic-response pathway studies

 

Grail Formula Quality

Every Grail Formula research peptide undergoes independent laboratory testing for purity, identity, structural integrity and microbial safety. All batches are verified for stability, low endotoxin levels and reproducibility to ensure reliable scientific outcomes.

When You Choose Grail Formula…

Researchers receive fully documented peptides with batch-number traceability, sealed-vial integrity and transparent laboratory verification. EU shipments include sterile bacteriostatic water; outside the EU only the peptide vial is supplied.

Used solely for in vitro experiments and cannot be:

• Used in clinical trials involving humans
• Administered to humans as part of an experiment or investigation
• Supplied to another party for human investigational use

• Independently verified to exceed 99 percent purity
• Validated for identity, structural integrity and stability
• High-quality regulatory signalling research peptide
• Consistent analytical behaviour in in-vitro modelling
• EU shipments include bacteriostatic water
• For research use only – not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.